Home›Companies›Biotech & Pharma›Caspian Therapeutics

Caspian Therapeutics, Inc.

Develops drug candidates for people with diabetes and other metabolic diseases.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 23, 2026·Suggest an edit

About Caspian Therapeutics

Caspian Therapeutics is a private company based in San Diego, California, incorporated in 2026 in Delaware. It has reported $50,000,000 raised in one offering on Form D since September 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 8, 2026Sep 23, 2026$50,000,000fully sold43$1.1MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Caspian Therapeutics's Form D filed Sep 23, 2026.

RS
Robert Spencer
President and Chief Operating Officer
TW
Troy Wilson
Executive Chairman
Also a director at Montara Therapeutics.
SL
Spike Loy
Director

Sources

  1. SECCaspian Therapeutics, Inc. filing history
  2. CompanyTerms of Use
  3. CompanyKO-7246 Development Strategy in Diabetes